HCA Healthcare Inc (NYSE:HCA) CMO Jonathan B. Perlin sold 38,480 shares of the business’s stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $102.05, for a total transaction of $3,926,884.00. Following the completion of the transaction, the chief marketing officer now directly owns 119,778 shares in the company, valued at $12,223,344.90. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
Shares of HCA Healthcare Inc (NYSE HCA) traded down $0.02 during trading on Tuesday, hitting $101.00. 1,410,000 shares of the stock were exchanged, compared to its average volume of 2,430,000. HCA Healthcare Inc has a 52-week low of $71.18 and a 52-week high of $106.84. The stock has a market capitalization of $35,760.00, a P/E ratio of 19.77, a price-to-earnings-growth ratio of 1.01 and a beta of 0.48. The company has a debt-to-equity ratio of -6.58, a quick ratio of 1.36 and a current ratio of 1.62.
HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, January 30th. The company reported $2.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.87 by $0.25. HCA Healthcare had a net margin of 4.89% and a negative return on equity of 49.49%. The firm had revenue of $11.56 billion for the quarter, compared to the consensus estimate of $11.19 billion. During the same period in the prior year, the firm posted $1.80 earnings per share. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. equities research analysts expect that HCA Healthcare Inc will post 8.71 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Friday, March 30th. Stockholders of record on Thursday, March 1st will be issued a $0.35 dividend. This represents a $1.40 dividend on an annualized basis and a dividend yield of 1.39%. The ex-dividend date of this dividend is Wednesday, February 28th.
Several institutional investors have recently made changes to their positions in the company. Advisor Partners LLC lifted its holdings in shares of HCA Healthcare by 13.5% in the fourth quarter. Advisor Partners LLC now owns 4,442 shares of the company’s stock worth $413,000 after buying an additional 528 shares in the last quarter. Parallel Advisors LLC lifted its holdings in shares of HCA Healthcare by 76.2% in the fourth quarter. Parallel Advisors LLC now owns 1,337 shares of the company’s stock worth $117,000 after buying an additional 578 shares in the last quarter. Ladenburg Thalmann Financial Services Inc. lifted its holdings in shares of HCA Healthcare by 8.3% in the third quarter. Ladenburg Thalmann Financial Services Inc. now owns 9,502 shares of the company’s stock worth $756,000 after buying an additional 729 shares in the last quarter. Amalgamated Bank lifted its holdings in shares of HCA Healthcare by 2.3% in the third quarter. Amalgamated Bank now owns 33,983 shares of the company’s stock worth $2,705,000 after buying an additional 754 shares in the last quarter. Finally, Mutual of America Capital Management LLC lifted its holdings in shares of HCA Healthcare by 2.2% in the third quarter. Mutual of America Capital Management LLC now owns 35,732 shares of the company’s stock worth $2,844,000 after buying an additional 761 shares in the last quarter. 74.14% of the stock is currently owned by hedge funds and other institutional investors.
A number of equities analysts recently weighed in on HCA shares. Cantor Fitzgerald reissued a “buy” rating and issued a $90.00 price target on shares of HCA Healthcare in a report on Tuesday, October 31st. Piper Jaffray Companies reissued a “buy” rating and issued a $82.00 price target on shares of HCA Healthcare in a report on Wednesday, November 1st. Mizuho dropped their price objective on shares of HCA Healthcare from $85.00 to $84.00 and set a “buy” rating on the stock in a report on Wednesday, November 1st. Jefferies Group dropped their price objective on shares of HCA Healthcare from $90.00 to $88.00 and set a “buy” rating on the stock in a report on Wednesday, November 1st. Finally, Credit Suisse Group began coverage on shares of HCA Healthcare in a report on Thursday, November 2nd. They set an “outperform” rating and a $95.00 price objective on the stock. Three investment analysts have rated the stock with a sell rating, six have assigned a hold rating and eighteen have given a buy rating to the company’s stock. HCA Healthcare presently has a consensus rating of “Buy” and an average target price of $104.50.
ILLEGAL ACTIVITY NOTICE: This news story was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international copyright laws. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2018/02/20/insider-selling-hca-healthcare-inc-hca-cmo-sells-38480-shares-of-stock.html.
HCA Healthcare Company Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.